GO:0097648 G protein-coupled receptor complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0097648 (G protein-coupled receptor complex) is a cellular_component term defined as a protein complex that contains G protein-coupled receptors.
• GPCR complexes assemble as monomers, homodimers, heterodimers and higher-order oligomers, and this assembly influences ligand binding and signalling output.
• Agonist binding stabilizes an active receptor conformation that engages heterotrimeric G proteins and initiates downstream signalling.
• GPCR complexes are not static: single-molecule and mass-spectrometry studies show dynamic conformational transitions and multiple coexisting receptor states.
• GPCR complex signalling intersects with mTORC1 regulation, linking receptor complexes to cell growth control.
• CRISPR knockout, point-mutation, knock-in and overexpression models are used to dissect the composition, assembly and function of GPCR complexes.
Description
GO:0097648, G protein-coupled receptor complex, is a Gene Ontology cellular_component term describing a protein complex that contains G protein-coupled receptors (GPCRs). GPCRs form the largest family of membrane receptors in eukaryotes and mediate cellular responses to hormones, neurotransmitters, photons and many other ligands. Because the term is defined at the level of the assembled receptor complex rather than a single polypeptide, it captures the idea that GPCR function depends on the physical organization of one or more receptor molecules together with their associated signalling partners. Understanding this complex is central to pharmacology, since most clinically used drugs target GPCRs or their signalling pathways. The complex is also a hub for signal integration: receptor complexes can couple to different G protein subtypes and to arrestin-dependent pathways, and their output is shaped by oligomerization, conformational dynamics and cellular context. Recent structural and pharmacological work has clarified how agonist binding stabilizes active receptor states and how these states engage downstream effectors. At the same time, single-molecule and aggregation studies have revealed that GPCR complexes are dynamic entities whose assembly and mobility can modulate signalling. For researchers, GO:0097648 provides a precise annotation target for experiments that ask which receptors, G proteins and accessory proteins co-assemble, how assembly changes with ligand exposure, and how complex composition relates to disease. This article summarizes the definition, composition, molecular mechanism, disease relevance and research methods for the G protein-coupled receptor complex, with all factual statements supported by the cited literature.
G protein-coupled receptor complex At A Glance
| GO ID | GO:0097648 |
|---|---|
| GO term | G protein-coupled receptor complex |
| Ontology | cellular_component |
| Synonym | G-protein coupled receptor complex |
| Definition | A protein complex that contains G protein-coupled receptors |
| Major function | Provides the assembled molecular platform for ligand recognition and G protein-mediated signal transduction |
| Composition | One or more GPCR polypeptides, often in association with heterotrimeric G proteins and accessory proteins |
| Assembly states | Monomer, homodimer, heterodimer and higher-order oligomer or aggregation states |
| Dynamic behaviour | Receptor complexes undergo conformational transitions and can exist in multiple coexisting states |
What Is GO:0097648?
According to the QuickGO definition, GO:0097648 (G protein-coupled receptor complex) is a protein complex that contains G protein-coupled receptors. In other words, the term does not describe a single GPCR polypeptide but the assembled molecular machine in which one or more GPCR molecules are physically associated, typically at the plasma membrane, and are competent to bind ligands and initiate signalling. The synonym G-protein coupled receptor complex refers to the same entity. Because the definition is deliberately broad, the term can annotate monomeric receptor complexes as well as dimeric, oligomeric or aggregation-dependent receptor assemblies, provided that GPCR molecules are present in the complex. This makes GO:0097648 useful for capturing the compositional and assembly aspects of GPCR biology that are not covered by terms describing individual receptors or downstream signalling events.
Why Is G protein-coupled receptor complex Important in Cell Biology?
The G protein-coupled receptor complex is important because it is the physical unit through which a large fraction of extracellular signals are converted into intracellular responses. GPCRs are targeted by a substantial proportion of approved drugs, and the efficacy of these drugs depends on the composition and conformational state of the receptor complex. Moreover, the complex is not a simple on-off switch: its assembly state, oligomerization and dynamic behaviour can change ligand pharmacology and downstream pathway selection. Studying GO:0097648 therefore helps researchers connect molecular structure to physiological signalling and to disease mechanisms.
• GPCR complexes mediate responses to hormones, neurotransmitters, photons and many other ligands.
• They are the primary targets of many clinically used drugs, making complex composition pharmacologically relevant.
• Oligomerization and aggregation can alter ligand binding and signalling output.
• Single-molecule studies show that GPCR complexes are dynamic and sample multiple conformational states.
• Mass-spectrometry approaches reveal receptor complex composition and post-translational modifications.
• GPCR complex signalling intersects with mTORC1 regulation and cell growth control.
• Dimerization has been proposed to influence receptor trafficking and pharmacology.
• Receptor complex assembly is a potential source of drug selectivity and side-effect profiles.
• Melatonin receptor complexes illustrate how structural knowledge of a specific GPCR informs signalling.
• CRISPR-based models allow causal testing of complex components in disease-relevant cells.
G protein-coupled receptor complex: biological process, structure and molecular mechanism
Ligand binding and receptor activation
In simple terms: A signal molecule docks onto the receptor and flips it into an active shape.
The first step in the activity of a G protein-coupled receptor complex is ligand recognition at the receptor binding pocket. Agonist binding stabilizes an active receptor conformation, a transition that has been resolved in structural and biophysical studies of GPCR activation. This conformational change is the molecular event that converts extracellular chemical information into an intracellular signal. Because the complex can contain more than one receptor molecule, ligand binding to one protomer may influence the conformational state of neighbouring protomers, a phenomenon relevant to dimeric and oligomeric receptor assemblies.
G protein coupling and nucleotide exchange
In simple terms: The activated receptor turns on a G protein, which then passes the message onward.
Once activated, the receptor complex engages heterotrimeric G proteins and promotes guanine nucleotide exchange on the G alpha subunit. This coupling step is a defining feature of GPCR signalling and is sensitive to the conformational state and assembly of the receptor complex. Different receptor complexes can couple preferentially to different G protein subtypes, and this selectivity contributes to pathway-specific signalling outcomes. The dynamic nature of the receptor-G protein interaction has been studied at the single-molecule level, revealing transient and heterogeneous coupling events.
Downstream signalling and pathway integration
In simple terms: The message spreads inside the cell and can branch into several routes.
Activated G proteins and receptor-associated effectors propagate signals to second-messenger systems and kinase cascades. GPCR complex signalling is not linear; it can intersect with growth-control pathways such as mTORC1, linking receptor activity to protein synthesis and cell growth. Mass-spectrometry-based pharmacology has expanded the inventory of signalling events and post-translational modifications associated with GPCR complexes. The complexity of GPCR modulation means that the same receptor complex can produce different outputs depending on cellular context and ligand bias.
Receptor complex assembly and oligomerization
In simple terms: Receptors can pair up or cluster, and the grouping changes how they behave.
The G protein-coupled receptor complex can exist as a monomer, homodimer, heterodimer or higher-order oligomer. Dimerization and oligomerization are proposed to influence ligand binding, receptor trafficking and signalling specificity. Physical studies of GPCR aggregation indicate that receptor clustering can modulate signalling activation, adding a layer of regulation beyond single-receptor pharmacology. Single-molecule imaging has shown that receptor complexes diffuse and assemble dynamically in the membrane, and that these dynamics correlate with signalling states.
Structural basis of complex function
In simple terms: The 3D shape of the receptor explains how it works and how drugs can change it.
Structural biology has provided atomic-level views of GPCR activation, including the conformational rearrangements that accompany agonist binding and G protein engagement. For specific receptors such as the melatonin receptor, structural and signalling studies have clarified how a particular GPCR complex recognizes its ligand and couples to downstream pathways. These structural insights are complemented by mass-spectrometry studies that map receptor complex composition and modifications. Together, structural and pharmacological data define the molecular basis of G protein-coupled receptor complex function.
Key Genes Involved in GO:0097648 G protein-coupled receptor complex
The following genes and proteins are central to the composition, assembly and signalling of the G protein-coupled receptor complex, based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ADRB2 | Prototypical GPCR that couples to Gs and is a classic model for receptor activation | Used to study agonist-induced conformational changes and complex assembly |
| DRD2 | Dopamine receptor GPCR involved in neurological signalling | Model for dimerization and pathway-selective signalling |
| OPRM1 | Opioid receptor GPCR mediating analgesic responses | Target for studying ligand bias and receptor complex pharmacology |
| HTR1A | Serotonin receptor GPCR linked to mood and behaviour | Used in heterodimer and signalling studies |
| MTNR1A | Melatonin receptor GPCR with resolved structure and signalling | Structural model for receptor complex activation |
| MTNR1B | Melatonin receptor GPCR involved in metabolic signalling | Model for receptor-specific signalling and drug design |
| GNAS | G alpha s subunit that couples to many GPCR complexes | Central to G protein coupling assays |
| GNAI1 | G alpha i subunit mediating inhibitory GPCR signalling | Used to dissect Gi-coupled receptor complexes |
| GNAQ | G alpha q subunit coupling GPCRs to calcium signalling | Model for Gq pathway analysis |
| ARRB1 | Beta-arrestin involved in GPCR desensitization and signalling | Key for biased signalling and complex regulation studies |
| ARRB2 | Beta-arrestin paralog with distinct GPCR interactions | Used in arrestin-dependent signalling models |
| GRK2 | G protein-coupled receptor kinase that phosphorylates activated receptors | Important for receptor complex desensitization studies |
| MTOR | Kinase integrating GPCR signalling with growth control | Links receptor complexes to mTORC1 regulation |
| RPTOR | Component of mTORC1 regulated downstream of GPCR signalling | Used to study GPCR-mTORC1 crosstalk |
| AKT1 | Kinase downstream of GPCR and growth signalling | Readout for GPCR-dependent growth pathways |
| PRKACA | cAMP-dependent kinase effector downstream of Gs-coupled complexes | Functional readout for Gs signalling |
| PLCB1 | Phospholipase C effector downstream of Gq-coupled complexes | Readout for Gq-mediated calcium signalling |
How Is G protein-coupled receptor complex Regulated?
The G protein-coupled receptor complex is regulated at multiple levels. Receptor activation is terminated or attenuated by phosphorylation and arrestin recruitment, processes that depend on the receptor complex state. Single-molecule studies show that receptor complexes are dynamic and that their mobility and assembly can be modulated by ligand exposure. Oligomerization adds another regulatory layer, since dimeric and higher-order assemblies can display altered pharmacology relative to monomers. In addition, GPCR complex signalling is integrated with mTORC1 regulation, providing a link between receptor activity and cellular growth control. Mass-spectrometry-based pharmacology has revealed that post-translational modifications and protein interactions further tune receptor complex function.
G protein-coupled receptor complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MTOR | Growth signalling and cancer-related pathways downstream of GPCR complexes | Knockout or point-mutation cell lines with GPCR stimulation |
| DRD2 | Neurological and psychiatric signalling | Knockout and heterodimer knock-in models |
| HTR1A | Mood and behaviour-related signalling | Receptor complex dimerization models |
| MTNR1A | Circadian and metabolic signalling | Structural and signalling knock-in models |
| ADRB2 | Cardiovascular and metabolic GPCR pharmacology | Tagged knock-in for single-molecule imaging |
GPCR complexes in cancer and growth signalling
GPCR complex signalling intersects with the mTORC1 pathway, which is a central regulator of cell growth and proliferation. Dysregulated GPCR activity can therefore contribute to aberrant growth signalling in cancer. Because mTORC1 integrates inputs from receptor complexes, targeting GPCR-mTORC1 crosstalk is an area of pharmacological interest. Experimental models that manipulate GPCR complex components can help determine whether a specific receptor complex drives growth-related phenotypes.
GPCR complexes in neurological and psychiatric disorders
Many GPCRs, including dopamine and serotonin receptors, are targets of drugs used in neurological and psychiatric conditions. Receptor dimerization and complex assembly can influence the pharmacology of these receptors, potentially affecting drug response. Studying the composition of GPCR complexes in neuronal cells may clarify why ligands with similar binding profiles produce different clinical effects. Single-molecule approaches can reveal how receptor complexes behave in relevant cellular contexts.
GPCR complexes in metabolic and endocrine signalling
Melatonin receptor complexes are involved in circadian and metabolic signalling, and their structures have been characterized. GPCR complexes that couple to Gs, Gi or Gq subunits participate in endocrine and metabolic regulation. Because these complexes can be targeted pharmacologically, understanding their assembly and signalling is relevant to metabolic disease research. Mass-spectrometry and structural methods provide tools to study these receptor complexes in detail.
From G protein-coupled receptor complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a GPCR required for a signalling response? | CRISPR knockout cell line |
| Does a specific residue control receptor activation? | Point-mutation knock-in |
| How does a disease-associated variant affect complex function? | Knock-in of the variant allele |
| Where and when is the receptor complex expressed? | Tagged knock-in with fluorescent or affinity tag |
| Does overexpression change signalling output? | Overexpression cell model |
| Which proteins co-assemble with the receptor? | Affinity purification and mass spectrometry |
How to Study the G protein-coupled receptor complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Mass spectrometry | Receptor complex composition and modifications | Identifying interacting proteins and post-translational changes |
| Single-molecule imaging | Dynamic behaviour of individual receptor complexes | Studying conformational transitions and diffusion |
| Structural biology | Three-dimensional architecture of activated receptor complexes | Understanding ligand recognition and G protein coupling |
| Second-messenger assays | cAMP, calcium or inositol phosphate levels | Measuring Gs, Gi or Gq pathway activity |
| mTORC1 activity assays | Downstream growth signalling | Linking GPCR complexes to cell growth control |
| BRET/FRET | Protein-protein interactions and conformational changes | Detecting receptor dimerization and complex assembly |
| Affinity purification | Physical association of receptor complex components | Isolating receptor complexes for proteomics |
| CRISPR perturbation | Causal role of a gene in complex function | Knockout or knock-in validation studies |
Mass spectrometry for receptor complex composition
Mass-spectrometry-based pharmacology has been used to characterize GPCR complexes, including receptor modifications and interacting proteins. This approach can identify post-translational changes and quantify ligand-dependent effects on complex composition. It is particularly useful when combined with affinity purification of tagged receptors.
Single-molecule imaging of receptor complexes
Single-molecule methods allow researchers to observe individual GPCR complexes in real time, revealing dynamic conformational transitions and diffusion behaviour. These techniques can detect transient assembly states that are averaged out in bulk assays. They are valuable for testing how ligands and mutations alter complex dynamics.
Structural biology of GPCR activation
Structural studies have defined the conformational changes that occur when a GPCR complex is activated by an agonist. Receptor-specific structures, such as those of melatonin receptors, provide templates for understanding ligand recognition and G protein coupling. These structures guide mutagenesis and drug-design experiments.
Signalling assays and pathway readouts
Functional assays measure second messengers, kinase activation and downstream transcriptional responses to assess GPCR complex activity. Because GPCR complexes can engage mTORC1 and other growth pathways, readouts such as mTORC1 activity can link receptor function to cell growth. Combining signalling assays with genetic perturbation helps establish causality.
How CRISPR Can Be Used to Study GO:0097648 G protein-coupled receptor complex
Knockout
CRISPR knockout of a GPCR gene or a G protein subunit removes the protein and allows researchers to test whether the G protein-coupled receptor complex is required for a given signalling response. Knockout models are useful for distinguishing receptor-dependent from receptor-independent effects. They can also reveal compensatory changes in related receptor complexes.
Point Mutation
Point-mutation models introduce specific amino acid changes to test the role of individual residues in receptor activation or coupling. Such models are guided by structural data on GPCR activation and can validate mechanisms proposed from structures. They are also used to study disease-associated variants.
Knock-in
Knock-in strategies can add tags, reporters or disease variants to endogenous GPCR genes, preserving native regulation of the receptor complex. Tagged knock-in receptors enable imaging and affinity purification of the complex from its native context. Disease-variant knock-in models help link genotype to complex function.
Overexpression
Overexpression of a GPCR or its partners can amplify signalling and facilitate biochemical detection of the receptor complex. However, overexpression may also promote aggregation or non-physiological assembly states, so results should be interpreted with care. Overexpression models are often used together with knockout or knock-in validation.
How EDITGENE Supports G protein-coupled receptor complex Research
Researchers studying G protein-coupled receptor complex-related genes often need to determine whether a candidate gene is causally involved in receptor assembly, signalling or disease phenotypes. Establishing causality typically requires precise genetic models in which a gene can be removed, mutated or tagged without confounding off-target effects. EDITGENE provides CRISPR-based cell model services that support this workflow, from knockout validation to knock-in reporter lines and library screening.
Contact EDITGENE today to design your custom CRISPR model for G protein-coupled receptor complex research.
Frequently Asked Questions About G protein-coupled receptor complex
What is GO:0097648?
GO:0097648 is the Gene Ontology cellular_component term for G protein-coupled receptor complex, defined as a protein complex that contains G protein-coupled receptors.
What is a G protein-coupled receptor complex?
It is an assembled protein complex containing one or more GPCRs, which can exist as monomers, dimers or higher-order oligomers and mediates ligand recognition and signalling.
What genes are involved in the G protein-coupled receptor complex?
Genes encoding GPCRs such as ADRB2, DRD2, OPRM1, HTR1A, MTNR1A and MTNR1B, as well as G protein subunits such as GNAS, GNAI1 and GNAQ, are central to the complex.
How does the G protein-coupled receptor complex work?
Agonist binding stabilizes an active receptor conformation that engages heterotrimeric G proteins and triggers downstream signalling.
Why is receptor dimerization important?
Dimerization and oligomerization can alter ligand binding, trafficking and signalling specificity of the receptor complex.
How is GPCR complex signalling regulated?
It is regulated by phosphorylation, arrestin recruitment, oligomerization and crosstalk with pathways such as mTORC1.
What diseases are linked to GPCR complexes?
GPCR complexes are linked to cancer-related growth signalling, neurological and psychiatric disorders, and metabolic signalling.
What methods study GPCR complexes?
Mass spectrometry, single-molecule imaging, structural biology and signalling assays are commonly used.
Can CRISPR be used to study GPCR complexes?
Yes, CRISPR knockout, point-mutation, knock-in and overexpression models are used to dissect receptor complex function.
What is the difference between a GPCR and a GPCR complex?
A GPCR is a single receptor polypeptide, whereas the GPCR complex is the assembled molecular entity that may include multiple receptors and associated proteins.
Conclusion
GO:0097648, G protein-coupled receptor complex, defines the assembled protein complex that contains GPCRs and serves as the physical platform for ligand recognition and signal transduction. Its composition, oligomerization state and dynamic behaviour shape pharmacological responses and disease-relevant signalling. CRISPR-based models provide a direct way to test the causal roles of complex components, and EDITGENE offers a full suite of knockout, point-mutation, knock-in, overexpression and screening services to support this research.
References
- 1. Weis WI et al.. 2018. The Molecular Basis of G Protein-Coupled Receptor Activation.. Annu Rev Biochem 87:897-919 PMID: 29925258
- 2. Melick CH et al.. 2022. G-Protein Coupled Receptor Signaling and Mammalian Target of Rapamycin Complex 1 Regulation.. Mol Pharmacol 101(4):181-190 PMID: 34965982
- 3. Dziedzicka-Wasylewska M et al.. 2024. G Protein-Coupled Receptor Dimerization-What Next?. Int J Mol Sci 25(6) PMID: 38542063
- 4. Yen HY et al.. 2023. G Protein-Coupled Receptor Pharmacology-Insights from Mass Spectrometry.. Pharmacol Rev 75(3):397-415 PMID: 36918259
- 5. Muneta-Arrate I et al.. 2025. The complexity of G protein-coupled receptor (GPCR) modulation and signalling.. Br J Pharmacol 182(14):3039-3043 PMID: 40347038
- 6. Watabe M et al.. 2020. Signaling activations through G-protein-coupled-receptor aggregations.. Phys Rev E 102(3-1):032413 PMID: 33076007
- 7. Calebiro D et al.. 2020. G Protein-Coupled Receptor Pharmacology at the Single-Molecule Level.. Annu Rev Pharmacol Toxicol 60:73-87 PMID: 31539479
- 8. Okamoto HH et al.. 2024. Melatonin receptor structure and signaling.. J Pineal Res 76(3):e12952 PMID: 38587234
